These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11496959)

  • 1. Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties.
    Boschi D; Caron G; Visentin S; Di Stilo A; Rolando B; Fruttero R; Gasco A
    Pharm Res; 2001 Jul; 18(7):987-91. PubMed ID: 11496959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.
    Cena C; Visentin S; Di Stilo A; Boschi D; Fruttero R; Gasco A
    Pharm Res; 2001 Feb; 18(2):157-65. PubMed ID: 11405285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
    Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
    J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.
    Visentin S; Rolando B; Di Stilo A; Fruttero R; Novara M; Carbone E; Roussel C; Vanthuyne N; Gasco A
    J Med Chem; 2004 May; 47(10):2688-93. PubMed ID: 15115410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
    Nguyen JT; Velázquez CA; Knaus EE
    Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO donor and biological properties of different benzofuroxans.
    Medana C; Di Stilo A; Visentin S; Fruttero R; Gasco A; Ghigo D; Bosia A
    Pharm Res; 1999 Jun; 16(6):956-60. PubMed ID: 10397620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
    López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
    Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers.
    Zorkun IS; Saraç S; Celebi S; Erol K
    Bioorg Med Chem; 2006 Dec; 14(24):8582-9. PubMed ID: 16971126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a new series of 4-aryl-1,4-dihydropyridines with calcium channel blocking and vasodilatory activity.
    Jain P; Narang G; Jindal DP; Bansal R; Calle C; Carron R; Pemberton K; Harvey AL
    Pharmazie; 2006 May; 61(5):400-5. PubMed ID: 16724534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
    Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
    J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic nitrates. II. Synthesis and biological activities of 4-nitrooxymethylphenyl-1,4-dihydropyridines.
    Lehmann J; Kahlich R; Meyer zum Gottesberge C; Fricke U
    Arch Pharm (Weinheim); 1997 Aug; 330(8):247-52. PubMed ID: 9361520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.